Kan-bayer, one of the world’s largest biotechnology company, uses science and innovation in an effort to dramatically improve people’s lives. Kan-bayer aspires to be the world’s best human therapeutics company. Our researchers harness the powerful tools of cellular and molecular biology and medicinal chemistry to discover, develop and commercialize naturally occurring proteins, antibodies and small molecules, with the goal of extending the reach of science to unleash the body’s own powerful therapeutic responses. Kan-bayer’s research and product development programs aim to help patients in the following therapeutic areas:hematology, inflammation, neurology, metabolic disorders and ageing. Kan-bayer’s marketed products include N G F、 EMBRIL、EPO-KAN、Bioblen、Anoxen HGH Evergene HGH.

Global and Growing: Headquartered approximately 10 miles north of Kansas; and beginning its third decade, Kan-bayer continues to grow. Kan-bayer now conducts business in 24 countries and has research, manufacturing, distribution, sales facilities and anti-ageing center worldwide.

Corporate History Founded in 1980, Kan-bayer pioneered development of novel and innovative products based on advances in recombinant DNA and molecularbiology. For more than two decades, Kan-bayer has played a leadership role in the translation of innovative science and technology into breakthrough human therapeutics.